Assessing Quality of Life (QOL) in Patients with Seizures Associated with Tuberous Sclerosis Complex (TSC)

被引：0
|
作者：
Bennett, B. [1 ]
Cooper, A. [2 ]
Fladrowski, C. [3 ]
Evanochko, C. [4 ]
Neary, M. [5 ]
Vieira, J. [6 ]
Buffa, V. [6 ]
Grant, L. [1 ]
Tritton, T. [1 ]
Kingswood, C. [7 ]
机构：
[1] Adelphi Values Ltd, Bollington, England
[2] Tuberous Sclerosis Assoc, London, England
[3] European Tuberous Sclerosis Assoc, Dattein, Germany
[4] Tuberous Sclerosis Assoc Canada, Barrie, ON, Canada
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Novartis Pharmaceut UK Ltd, Frimley, Surrey, England
[7] St George Hosp, London, England
来源：
EPILEPSIA | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
p724
引用
收藏
页码：S331 / S332
页数：2
相关论文
共 50 条
  • [21] Family reflections: tuberous sclerosis complex (TSC)
    Meitzler, Shelly
    [J]. PEDIATRIC RESEARCH, 2021, 89 (06) : 1578 - 1579
  • [22] Advances in Tuberous Sclerosis Complex (TSC) research
    Underwood, Lisa
    [J]. ADVANCES IN AUTISM, 2016, 2 (02) : 59 - 69
  • [23] EVEROLIMUS REDUCES SEIZURE ACTIVITY IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC)
    Franz, D. N.
    Tillema, J. M.
    Care, M. M.
    Holland-Bouley, K.
    Agricola, K.
    Tudor, C.
    Mangeshkar, P.
    Weber-Byars, A.
    Sahmoud, T.
    Krueger, D. A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 568 - 568
  • [24] Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex
    Vergeer, Menno
    de Ranitz-Greven, Wendela L.
    Neary, Maureen P.
    Ionescu-Ittu, Raluca
    Emond, Bruno
    Duh, Mei Sheng
    Jansen, Floor
    Zonnenberg, Bernard A.
    [J]. EPILEPSIA OPEN, 2019, 4 (04) : 581 - 592
  • [25] Exposure-response analysis of adjunctive everolimus therapy in patients with refractory partial-onset seizures associated with tuberous sclerosis complex (TSC)
    French, J.
    Lawson, J.
    Yapici, Z.
    Polster, T.
    Nabbout, R.
    Curatolo, P.
    de Vries, P.
    Berkowitz, N.
    Voi, M.
    Peyrard, S.
    Vaury, A.
    Franz, D. N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 54 - 54
  • [26] TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex
    Muzykewicz, D. A.
    Sharma, A.
    Muse, V.
    Numis, A. L.
    Rajagopal, J.
    Thiele, E. A.
    [J]. JOURNAL OF MEDICAL GENETICS, 2009, 46 (07) : 465 - 468
  • [27] RENAL EVALUATION OF PAEDIATRIC PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC) IN A NATIONAL TSC MULTIDISCIPLINARY CLINIC
    Patterson, Jenny
    Joss, Shelagh
    Shaheen, Ihab
    [J]. PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1753 - 1753
  • [28] Pharmacotherapy for Seizures in Tuberous Sclerosis Complex
    Nabbout, Rima
    Kuchenbuch, Mathieu
    Chiron, Catherine
    Curatolo, Paolo
    [J]. CNS DRUGS, 2021, 35 (09) : 965 - 983
  • [29] Population pharmacokinetics–pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex
    François Pierre Combes
    Guillaume Baneyx
    Neva Coello
    Penny Zhu
    William Sallas
    Hequn Yin
    Jerry Nedelman
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2018, 45 : 707 - 719
  • [30] Quality of life and its predictors in adults with tuberous sclerosis complex (TSC): a multicentre cohort study from Germany
    Zoellner, Johann Philipp
    Conradi, Nadine
    Sauter, Matthias
    Knuf, Markus
    Knake, Susanne
    Kurlemann, Gerhard
    Mayer, Thomas
    Hertzberg, Christoph
    Bertsche, Astrid
    Immisch, Ilka
    Klein, Karl Martin
    Marquard, Klaus
    Meyer, Sascha
    Noda, Anna H. H.
    von Podewils, Felix
    Schaefer, Hannah
    Thiels, Charlotte
    Zukunft, Bianca
    Schubert-Bast, Susanne
    Grau, Janina
    Willems, Laurent M. M.
    Rosenow, Felix
    Reese, Jens-Peter
    Strzelczyk, Adam
    [J]. NEUROLOGICAL RESEARCH AND PRACTICE, 2021, 3 (01):
12345